Harrington KJ - Search Results

1

Intratumoral therapies in head and neck squamous cell carcinoma: A systematic review and future perspectives.

Jiménez-Labaig P, Rullan A, Braña I, Hernando-Calvo A, Moreno V, Doger B, Bitar G, Ap Dafydd D, Melcher A, Harrington KJ. Jiménez-Labaig P, et al. Among authors: harrington kj. Cancer Treat Rev. 2024 Jun;127:102746. doi: 10.1016/j.ctrv.2024.102746. Epub 2024 Apr 27. Cancer Treat Rev. 2024. PMID: 38696902 Review.

2

Cancer gene therapy: Part 1. Vector development and regulation of gene expression.

Harrington KJ, Bateman AR, Melcher AA, Ahmed A, Vile RG. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 2002 Feb;14(1):3-16. doi: 10.1053/clon.2001.0002. Clin Oncol (R Coll Radiol). 2002. PMID: 11898782 Review. No abstract available.

3

Cancer gene therapy: Part 2. Candidate transgenes and their clinical development.

Harrington KJ, Melcher AA, Bateman AR, Ahmed A, Vile RG. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 2002 Apr;14(2):148-69. doi: 10.1053/clon.2001.0004. Clin Oncol (R Coll Radiol). 2002. PMID: 12069125 Review. No abstract available.

4

Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting?

Hingorani M, White CL, Agrawal VK, Vidal L, Melcher A, Harrington KJ. Hingorani M, et al. Among authors: harrington kj. Curr Cancer Drug Targets. 2007 Jun;7(4):389-409. doi: 10.2174/156800907780809787. Curr Cancer Drug Targets. 2007. PMID: 17979632 Review.

5

Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy.

Twigger K, Vidal L, White CL, De Bono JS, Bhide S, Coffey M, Thompson B, Vile RG, Heinemann L, Pandha HS, Errington F, Melcher AA, Harrington KJ. Twigger K, et al. Among authors: harrington kj. Clin Cancer Res. 2008 Feb 1;14(3):912-23. doi: 10.1158/1078-0432.CCR-07-1400. Clin Cancer Res. 2008. PMID: 18245555

6

Exploiting synergies between radiation and oncolytic viruses.

Harrington KJ, Melcher A, Vassaux G, Pandha HS, Vile RG. Harrington KJ, et al. Curr Opin Mol Ther. 2008 Aug;10(4):362-70. Curr Opin Mol Ther. 2008. PMID: 18683101 Review.

7

Oncolytic viruses: a novel form of immunotherapy.

Prestwich RJ, Harrington KJ, Pandha HS, Vile RG, Melcher AA, Errington F. Prestwich RJ, et al. Among authors: harrington kj. Expert Rev Anticancer Ther. 2008 Oct;8(10):1581-8. doi: 10.1586/14737140.8.10.1581. Expert Rev Anticancer Ther. 2008. PMID: 18925850 Free PMC article. Review.

8

A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer.

Vidal L, Pandha HS, Yap TA, White CL, Twigger K, Vile RG, Melcher A, Coffey M, Harrington KJ, DeBono JS. Vidal L, et al. Among authors: harrington kj. Clin Cancer Res. 2008 Nov 1;14(21):7127-37. doi: 10.1158/1078-0432.CCR-08-0524. Clin Cancer Res. 2008. PMID: 18981012 Clinical Trial.

9

Tumor infection by oncolytic reovirus primes adaptive antitumor immunity.

Prestwich RJ, Errington F, Ilett EJ, Morgan RS, Scott KJ, Kottke T, Thompson J, Morrison EE, Harrington KJ, Pandha HS, Selby PJ, Vile RG, Melcher AA. Prestwich RJ, et al. Among authors: harrington kj. Clin Cancer Res. 2008 Nov 15;14(22):7358-66. doi: 10.1158/1078-0432.CCR-08-0831. Clin Cancer Res. 2008. PMID: 19010851 Free PMC article.

10

Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors.

Hingorani M, White CL, Merron A, Peerlinck I, Gore ME, Slade A, Scott SD, Nutting CM, Pandha HS, Melcher AA, Vile RG, Vassaux G, Harrington KJ. Hingorani M, et al. Among authors: harrington kj. Cancer Res. 2008 Dec 1;68(23):9771-8. doi: 10.1158/0008-5472.CAN-08-1911. Cancer Res. 2008. PMID: 19047156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters